Skip to content

Actipulse Neuroscience

YC W22 · Active · Bringing non-invasive brain stimulation from the hospital to the home

Competitors

Adjacent

Also from W22

All of W22

About Actipulse Neuroscience

Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application. Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment. Currently in FDA pivotal phase for Major Depressive Disorder, and Pilot phase for Alzheimer's and Parkinson diseases.

YC batch
W22 · Winter 2022
Status, per YC
Active
Category
Other
Team size
38
Location
Mexico City, CDMX, Mexico
Checked
35m ago

YC tags: Mental Health Tech, Neurotechnology, Medical Devices

Actipulse Neuroscience in W22: 398 companies, 44% AI

Actipulse Neuroscience: questions

Which YC batch was Actipulse Neuroscience in?

Actipulse Neuroscience was in Y Combinator's Winter 2022 batch (W22).

Is Actipulse Neuroscience still active?

Y Combinator lists Actipulse Neuroscience as active.

Where is Actipulse Neuroscience based?

Actipulse Neuroscience lists Mexico City, CDMX, Mexico as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.